palivizumab
Showing 1 - 6 of 6
Healthy Adult Participants Trial in London (Palivizumab, Placebo, RSV-A Memphis 37b virus)
Completed
- Healthy Adult Participants
- Palivizumab
- +2 more
-
London, United KingdomhVIVO Services Limited
Sep 7, 2021
Respiratory Syncytial Virus Infections Trial in Worldwide (MEDI8897, Palivizumab)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- MEDI8897
- Palivizumab
-
Anaheim, California
- +127 more
Aug 18, 2022
Respiratory Syncytial Virus-bronchiolitis Trial in Doha (Palivizumab, Placebo)
Completed
- Respiratory Syncytial Virus-bronchiolitis
- Palivizumab
- Placebo
-
Doha, QatarHamad Medical Corporation
Feb 26, 2018
Respiratory Syncytial Virus (RSV) Trial (Palivizumab)
Completed
- Respiratory Syncytial Virus (RSV)
- Palivizumab
- (no location specified)
Feb 9, 2018
Respiratory Syncytial Virus Infection Trial in Japan (Palivizumab)
Completed
- Respiratory Syncytial Virus Infection
- Palivizumab
-
Hyogo, Japan
- +5 more
Jun 13, 2013
Cancer Trial in Seattle (palivizumab, ribavirin)
Completed
- Cancer
- palivizumab
- ribavirin
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Mar 31, 2010